Featured Research

from universities, journals, and other organizations

'MicroRNA' could be key target for bowel cancer treatment

Date:
April 14, 2014
Source:
Institute of Cancer Research
Summary:
A tiny genetic molecule known as a microRNA plays a central role in bowel cancer and could be key to developing new treatments for the disease, a new study concludes. Drugs targeted at the microRNA could knock out the effects of multiple cancer-causing mutations at once, while tests for it could identify patients with the most aggressive disease, the researchers believe.

Scientists found that the molecule, called microRNA 135b, is a vital 'worker' employed by several important cancer genes to drive the growth of bowel cancers.

Drugs targeted at the microRNA could knock out the effects of multiple cancer-causing mutations at once, while tests for it could identify patients with the most aggressive disease, the researchers believe.

The research was carried out by an international team including scientists based at The Institute of Cancer Research, London, the University of Glasgow and Ohio State University in the US.

Scientists tested for microRNA 135b in 485 patients with bowel cancer and found that levels were at least four times as high in tumours as in healthy tissue, and that patients with the highest levels survived the least long.

They showed that blocking the microRNA stopped tumour growth in bowel cancer mouse models, and in half of them tumours regressed so dramatically they could no longer be seen by imaging. Mice didn't show any side-effects as a result of treatment.

The study is published in the journal Cancer Cell, with funding for the UK research team coming from the Kimmel Cancer Foundation, Cancer Research UK, The Marie Curie Actions Programme and a Scottish Senior Clinical Research Fellowship.

MicroRNAs are small strands of genetic material that regulate gene activity and are involved many cellular processes.

The study showed that a number of known cancer gene mutations, such as APC, PI3KCA, SRC and p53, exercise their effects through microRNA 135b.

Although treatments targeting bowel cancer mutations have been developed, patients often develop resistance. Inhibiting microRNA 135b could be an exciting way to attack cancers without resistance occurring by blocking the effects of multiple cancer-causing mutations simultaneously.

The findings also suggest that testing levels of microRNA 135b could help identify patients likely to develop aggressive bowel cancer, and who might need the most intensive treatment.

Lead author Dr Nicola Valeri, Leader of the Gastrointestinal Cancer Biology and Genomics Team at The Institute of Cancer Research, London, said:

"We have shown that a specific microRNA can drive the development of bowel cancers and is a key 'worker' responsible for putting into action the instructions from many cancer-causing mutations. Patients with the highest levels of this molecule have the most difficult-to-treat cancers, and inhibiting the molecule in mice prevents tumours from growing. Although the research is at an early stage, our findings may have an important impact in the way we treat patients with bowel cancer in the future."

Professor Paul Workman, Deputy Chief Executive of The Institute of Cancer Research, London, said: "This work sheds light on the important role of microRNAs in bowel cancer and opens up a potentially exciting new avenue for cancer treatment. It also gives us a marker of disease that might prove valuable in the clinic to predict which patients have a more aggressive cancer.

"MicroRNAs play a vital role in the cells in our body, both in normal functions and in disease. We have known for a while that microRNAs are important in cancer, but their diversity of roles has meant it's been difficult to target them with drugs without causing toxic side-effects. This particular RNA has a huge advantage that might allow us to avoid this toxicity, because it is found in very low levels in normal tissue and in high levels in cancer."

Professor Owen Sansom, Deputy Director of The Cancer Research UK Beatson Institute at Glasgow University, said: "This exciting work shows a single microRNA can control multiple pathways that go wrong in colon cancer and offers the hope that in the future this could be targeted in patients that have colon cancer."


Story Source:

The above story is based on materials provided by Institute of Cancer Research. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nicola Valeri, Chiara Braconi, Pierluigi Gasparini, Claudio Murgia, Andrea Lampis, Viola Paulus-Hock, JonathanR. Hart, Lynn Ueno, SergeiI. Grivennikov, Francesca Lovat, Alessio Paone, Luciano Cascione, KhleaM. Sumani, Angelo Veronese, Muller Fabbri, Stefania Carasi, Hansjuerg Alder, Giovanni Lanza, Roberta Gafa’, MaryP. Moyer, RachelA. Ridgway, Julia Cordero, GerardJ. Nuovo, WendyL. Frankel, Massimo Rugge, Matteo Fassan, Joanna Groden, PeterK. Vogt, Michael Karin, OwenJ. Sansom, CarloM. Croce. MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer. Cancer Cell, 2014; 25 (4): 469 DOI: 10.1016/j.ccr.2014.03.006

Cite This Page:

Institute of Cancer Research. "'MicroRNA' could be key target for bowel cancer treatment." ScienceDaily. ScienceDaily, 14 April 2014. <www.sciencedaily.com/releases/2014/04/140414123741.htm>.
Institute of Cancer Research. (2014, April 14). 'MicroRNA' could be key target for bowel cancer treatment. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2014/04/140414123741.htm
Institute of Cancer Research. "'MicroRNA' could be key target for bowel cancer treatment." ScienceDaily. www.sciencedaily.com/releases/2014/04/140414123741.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins